期刊文献+

辛伐他汀消退老年载脂蛋白E基因敲除小鼠动脉粥样硬化斑块的观察 被引量:2

Effect of simvastatin therapy on regression of atherosclerotic plaque in old apoE gene-deleted mice
下载PDF
导出
摘要 目的观察辛伐他汀对高脂喂养的老年载脂蛋白E(apoE)基因敲除小鼠动脉粥样硬化(AS)斑块的作用。方法选取高脂喂养的60周龄雄性aopE基因敲除小鼠30只,随机分为辛伐他汀高剂量组、辛伐他汀低剂量组和模型组,每组10只,分别每天予以辛伐他汀20mg/kg、辛伐他汀5mg/kg和等量生理盐水灌胃,连续灌胃8周后,取主动脉窦部做病理检测。冷冻切片光镜下观察AS斑块病理情况,免疫组织化学染色观察骨桥蛋白、α肌动蛋白的表达。vonkossa染色观察斑块钙化情况。结果与模型组比较,辛伐他汀高、低剂量组apoE基因敲除小鼠的血清TC和LDL-C水平明显降低(P<0.05),斑块面积占管腔面积比、斑块内钙化染色面积明显减少(P<0.05)。结论辛伐他汀可明显降低老年apoE基因敲除小鼠的血清TC和LDL-C水平,消退AS斑块的大小及其钙化。 Objective To investigate the effect of simvastatin on regression of atherosclerotic(AS) plaque in old apolipoprotein E gene(apoE)-deleted mice. Methods Thirty 60-week-old apoE-deleted mice exhibiting advanced atherosclerotic plaques were randomly divided into three groups: model group, high-dose simvastatin-treated group, and regular simvastatin-treated group. They were administered with saline, simvastatin 20 mg/kg per day, and simvastatin 5 mg/kg per day for 8 weeks respectively. After that,the mice were sacrificed for examination of serum lipids and aortic sinus was taken for pathological examination. Frozen slides of aorta were stained with hematoxylin and eosin, oil red O stain, histochemical stains for OPN and α-actin and von Kossa stain. Analysis was performed with a computerized image analysis program (Image Pro Plus). Results Serum cholesterol levels were significantly decreased (P 〈0.05) and histological analysis of sections of aorta demonstrated a significant reduction in cross-sectional area of atherosclerotic lesions (P〈0.05) and the frequency of calcification in atherosclerotic plaques (P〈0. 01) in the simvastatin-treated mice compared with control mice. Conclusions The resuts indicated that serum cholesterol levels were significantly decreased in the simvastatin-treated mice compared with control mice. Simvastatin has anti-atherosclerotic effects on advanced atherosclerotic lesions.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2008年第5期361-363,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(30470267)
关键词 斯伐他汀 载脂蛋白E类 小鼠 基因敲除 动脉硬化 simvastatin apolipoproteins E mice,knockout arteriosclerosis
  • 相关文献

参考文献1

二级参考文献22

  • 1Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504.
  • 2LaRosa JC, Grundy SM, Waters DD, et al; Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425-1435.
  • 3Pedersen TR, Faergeman O, Kastelein J J, et al; Incremental Decrease in End Points Through Aggressive Lipid Lowedng (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study:a randomized controlled trial. JAMA. 2005;294:2437-2445.
  • 4Grundy SM, Cleeman JI, Merz CN, et al; Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ Guidelines. J Am Coll Cardiol. 2004;44:720-732.
  • 5Blankenhom DH, Azen SP, Kramsch DM, et al;MARS Research Group. Coronary angiographic changes with Iovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med.1993;119:969-976.
  • 6Waters D, Higginson L, Gladstone P, et al. Effects of monotherapy with HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed be serial quantitaUve arteriography: the Canadian Coronary Atherosclerosis Intervention Trial(CCAIT). Circulation. 1994;89:959-968.
  • 7Jukema JW, Bruschke AV, van Boven A J, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995;91:2528-2540.
  • 8Pitt B, Mancini GB, Ellis SG, Rosrnan HS, Park J-S,McGovem ME. Pravastatin limitaUon of atherosclerosis in the coronary arteries (PLAC Ⅰ): reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol. 1995;26:1133-1139.
  • 9Brown G, Albers J J, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipidlowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298.
  • 10MAAS Study Group. Effect of simvastatin on coronary atheroma: the Multicentre Anti-atheroma Study( MAAS). Lancet. 1994;344:633 -638.

共引文献345

同被引文献41

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部